INVESTOR LOGIN

LRG BayStar Capital Funds Portfolio

PORTFOLIO COMPANIES

Please find some the portfolio of current and prior LRG BayStar Capital Funds' portfolio companies below:

Orthovita, Inc. (VITA)

Orthovita, Inc. (VITA)

Orthovita, Inc. is a developer of biomaterials and orthobiologicals focused on synthetic bone substitute products for orthopedic applications primarily in the spine. 
http://www.orthovita.com

PharmaNetics, Inc

PharmaNetics, Inc

PharmaNetics, Inc. is a leading biotechnology company that has developed new technologies that bring the power of a personal laboratory directly to a patient’s bedside in real time.
 

Targeted Genetics Corporation (TGEN)

Targeted Genetics Corporation (TGEN)

Targeted Genetics Corporation is a developer of gene delivery technology and therapeutic products for treating acquired and inherited diseases.

 
  http://www.targen.com

Transkaryotic Therapies, Inc.

Transkaryotic Therapies, Inc.

Transkaryotic Therapies, Inc. is a biopharmaceutical company dedicated to the development and commercialization of gene therapy products designed for the long-term treatment of chronic protein deficiency diseases. 

Trega Biosciences, Inc.

Trega Biosciences, Inc.

Trega Biosciences is an information-driven company focused on accelerating drug discovery from disease targets to clinical candidates through its iDiscovery technologies.
 

 
Arque Capital
This website is for general informational purposes only and is not intended as a solicitation or offering for any investment product or service.
LRG Capital Group, in alliance with Arque Capital, Ltd. Member FINRA/SIPC